Top Markets
#1 Akedo Akedo +64.36%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.34%
#4 Cross Cross +45.41%
#5 Black Phoenix Black Phoenix +34.24%
#6 Velvet Velvet +30.05%
#7 OVERTAKE OVERTAKE +26.38%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.75%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.03%
#10 Palladium Network Palladium Network +12.84%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

BLCM
Classement en actions #38877
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage... Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lymphomas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.
Prix de l'action
$0.07475
Dernière synchronisation: 2024-03-04
Capitalisation boursière
$755.60K
Changement (1 jour)
-6.68%
Changement (1 an)
0.00%
Pays
US
Échange Bellicum Pharmaceuticals, Inc. (BLCM)

Catégorie

Healthcare
Le prix BLCM avec la capitalisation boursière de B
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.
BLCM
$0.07475
Capitalisation boursière de Bellicum Pharmaceuticals, Inc.(BLCM)
Capitalisation boursière: $755.60K
En August 2026, Bellicum Pharmaceuticals, Inc. a une capitalisation boursière de $755.60K. Cela fait de Bellicum Pharmaceuticals, Inc. la 38877th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Bellicum Pharmaceuticals, Inc. du 2014 au 2026
BLCM par rapport au top 5 des plus populaires stocks
Prix pour BLCM L’actif B La capitalisation boursière de B Résultats
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.
$541,885 $755.60K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.478T +724,929,046.33%
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.
$444,011 $755.60K
Apple Inc. Apple Inc.
AAPL
$4.488T +593,994,561.20%
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.
$411,882 $755.60K
Alphabet Inc. Alphabet Inc.
GOOG
$4.163T +551,012,739.79%
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.
$366,474 $755.60K
Microsoft Corporation Microsoft Corporation
MSFT
$3.704T +490,265,723.71%
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.
$281,102 $755.60K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.841T +376,056,071.60%